INZY
Price:
$4.98
Market Cap:
$312.42M
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2020-07-24
Stock Exchange
NASDAQ
Ticker
INZY
According to Inozyme Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.46. This represents a change of -1.12% compared to the average of -3.50 of the last 4 quarters.
The mean historical PE Ratio of Inozyme Pharma, Inc. over the last ten years is -9.66. The current -3.46 PE Ratio has changed 3.48% with respect to the historical average. Over the past ten years (40 quarters), INZY's PE Ratio was at its highest in in the December 2022 quarter at -0.60. The PE Ratio was at its lowest in in the September 2019 quarter at -16.47.
Average
-9.66
Median
-3.10
Minimum
-38.13
Maximum
0
Discovering the peaks and valleys of Inozyme Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 412.16%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -38.13
Year | PE Ratio | Change |
---|---|---|
2023 | -3.10 | 412.16% |
2022 | -0.61 | -78.73% |
2021 | -2.85 | -67.05% |
2020 | -8.64 | -39.47% |
2019 | -14.28 | -62.54% |
2018 | -38.13 | -Infinity% |
The current PE Ratio of Inozyme Pharma, Inc. (INZY) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.19
5-year avg
-5.90
10-year avg
-9.66
Inozyme Pharma, Inc.’s PE Ratio is greater than Day One Biopharmaceuticals, Inc. (-7.39), less than X4 Pharmaceuticals, Inc. (7.41), less than Acumen Pharmaceuticals, Inc. (-2.06), greater than Mereo BioPharma Group plc (-18.18), greater than Terns Pharmaceuticals, Inc. (-6.06), less than PDS Biotechnology Corporation (-2.64), less than HOOKIPA Pharma Inc. (-1.22), less than Eledon Pharmaceuticals, Inc. (-1.43), less than Amylyx Pharmaceuticals, Inc. (-0.97),
Company | PE Ratio | Market cap |
---|---|---|
-7.39 | $1.25B | |
7.41 | $109.78M | |
-2.06 | $133.38M | |
-18.18 | $664.26M | |
-6.06 | $549.60M | |
-2.64 | $107.88M | |
-1.22 | $159.50M | |
-1.43 | $100.73M | |
-0.97 | $161.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inozyme Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Inozyme Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Inozyme Pharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Inozyme Pharma, Inc. (INZY)?
What is the highest PE Ratio for Inozyme Pharma, Inc. (INZY)?
What is the 3-year average PE Ratio for Inozyme Pharma, Inc. (INZY)?
What is the 5-year average PE Ratio for Inozyme Pharma, Inc. (INZY)?
How does the current PE Ratio for Inozyme Pharma, Inc. (INZY) compare to its historical average?